Literature DB >> 16244875

Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: clinical association.

E K Tan1, K Y Puong, D K Y Chan, K Yew, S Fook-Chong, H Shen, P W Ng, J Woo, Y Yuen, R Pavanni, M C Wong, K Puvan, Y Zhao.   

Abstract

We provided data to show that the transcriptional activity of wildtype -258T in the parkin promoter region was significantly higher than the -258G variant in human cell lines. The transcriptional activity of wildtype -258T was significantly increased under oxidative stress by hydrogen peroxide, but this was not observed for the -258G variant. The transcriptional upregulation was significantly higher for wildtype -258T compared to -258G variant at 0.1, 0.2 and 0.4 mM of hydrogen peroxide. Similar results were obtained when the cells were treated with a proteasome inhibitor, MG132.Furthermore, in a case control study involving 753 subjects, we demonstrated that the parkin promoter -258G variant was associated with an increased risk of sporadic Parkinson's disease (PD) in the elderly ethnic Chinese population. Our clinical and laboratory data provide corroborative evidence that some older individuals who have the -258G variant may have a higher risk of developing PD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16244875     DOI: 10.1007/s00439-005-0038-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  Variability and validity of polymorphism association studies in Parkinson's disease.

Authors:  E K Tan; M Khajavi; J I Thornby; S Nagamitsu; J Jankovic; T Ashizawa
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

2.  Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.

Authors:  Leonard Petrucelli; Casey O'Farrell; Paul J Lockhart; Melisa Baptista; Kathryn Kehoe; Liselot Vink; Peter Choi; Benjamin Wolozin; Matthew Farrer; John Hardy; Mark R Cookson
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

Review 3.  Parkin genetics: one model for Parkinson's disease.

Authors:  Ignacio F Mata; Paul J Lockhart; Matthew J Farrer
Journal:  Hum Mol Genet       Date:  2004-02-19       Impact factor: 6.150

4.  Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome.

Authors:  Dong-Hoon Hyun; MoonHee Lee; Nobutaka Hattori; Shin-Ichiro Kubo; Yoshikuni Mizuno; Barry Halliwell; Peter Jenner
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

5.  Functional association of the parkin gene promoter with idiopathic Parkinson's disease.

Authors:  Andrew B West; Demetrius Maraganore; Julia Crook; Tim Lesnick; Paul J Lockhart; Kristen M Wilkes; Gregory Kapatos; John A Hardy; Matt J Farrer
Journal:  Hum Mol Genet       Date:  2002-10-15       Impact factor: 6.150

6.  Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age.

Authors:  Aaron C Pawlyk; Benoit I Giasson; Deepak M Sampathu; Francisco A Perez; Kah Leong Lim; Valina L Dawson; Ted M Dawson; Richard D Palmiter; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2003-09-12       Impact factor: 5.157

7.  Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.

Authors:  Sofia A Oliveira; William K Scott; Martha A Nance; Ray L Watts; Jean P Hubble; William C Koller; Kelly E Lyons; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; Joseph Jankovic; William G Ondo; Fred H Allen; Burton L Scott; Christopher G Goetz; Gary W Small; Frank L Mastaglia; Jeffrey M Stajich; Fengyu Zhang; Michael W Booze; Joshua A Reaves; Lefkos T Middleton; Jonathan L Haines; Margaret A Pericak-Vance; Jeffery M Vance; Eden R Martin
Journal:  Arch Neurol       Date:  2003-07

8.  Polymorphism in the parkin gene in sporadic Parkinson's disease.

Authors:  M Wang; N Hattori; H Matsumine; T Kobayashi; H Yoshino; A Morioka; T Kitada; S Asakawa; S Minoshima; N Shimizu; Y Mizuno
Journal:  Ann Neurol       Date:  1999-05       Impact factor: 10.422

9.  Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

Authors:  Alexander Zimprich; Saskia Biskup; Petra Leitner; Peter Lichtner; Matthew Farrer; Sarah Lincoln; Jennifer Kachergus; Mary Hulihan; Ryan J Uitti; Donald B Calne; A Jon Stoessl; Ronald F Pfeiffer; Nadja Patenge; Iria Carballo Carbajal; Peter Vieregge; Friedrich Asmus; Bertram Müller-Myhsok; Dennis W Dickson; Thomas Meitinger; Tim M Strom; Zbigniew K Wszolek; Thomas Gasser
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

10.  A common LRRK2 mutation in idiopathic Parkinson's disease.

Authors:  William P Gilks; Patrick M Abou-Sleiman; Sonia Gandhi; Shushant Jain; Andrew Singleton; Andrew J Lees; Karen Shaw; Kailash P Bhatia; Vincenzo Bonifati; Niall P Quinn; John Lynch; Daniel G Healy; Janice L Holton; Tamas Revesz; Nicholas W Wood
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

View more
  5 in total

1.  Parkinson's disease in China.

Authors:  You-yong Tian; Cui-ju Tang; Jie Wu; Jun-shan Zhou
Journal:  Neurol Sci       Date:  2010-12-14       Impact factor: 3.307

2.  The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.

Authors:  E K Tan; Y Zhao; L Skipper; M G Tan; A Di Fonzo; L Sun; S Fook-Chong; S Tang; E Chua; Y Yuen; L Tan; R Pavanni; M C Wong; P Kolatkar; C S Lu; V Bonifati; J J Liu
Journal:  Hum Genet       Date:  2006-09-30       Impact factor: 4.132

3.  Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease.

Authors:  Owen A Ross; Kristoffer Haugarvoll; Jeremy T Stone; Michael G Heckman; Linda R White; Jan O Aasly; J Mark Gibson; Timothy Lynch; Zbigniew K Wszolek; Ryan J Uitti; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2007-04-02       Impact factor: 4.891

4.  Parkin is protective against proteotoxic stress in a transgenic zebrafish model.

Authors:  Mareike E Fett; Anna Pilsl; Dominik Paquet; Frauke van Bebber; Christian Haass; Jörg Tatzelt; Bettina Schmid; Konstanze F Winklhofer
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

5.  Mapping of PARK2 and PACRG overlapping regulatory region reveals LD structure and functional variants in association with leprosy in unrelated indian population groups.

Authors:  Rupali Chopra; Shafat Ali; Amit K Srivastava; Shweta Aggarwal; Bhupender Kumar; Siddharth Manvati; Ponnusamy Kalaiarasan; Mamta Jena; Vijay K Garg; Sambit N Bhattacharya; Rameshwar N K Bamezai
Journal:  PLoS Genet       Date:  2013-07-04       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.